1570 related articles for article (PubMed ID: 12516033)
1. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
Ferrara N
Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
[TBL] [Abstract][Full Text] [Related]
2. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
Jain RK
Semin Oncol; 2002 Dec; 29(6 Suppl 16):3-9. PubMed ID: 12516032
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
4. The role of vascular endothelial growth factor in angiogenesis.
Ferrara N; Gerber HP
Acta Haematol; 2001; 106(4):148-56. PubMed ID: 11815711
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic anti-VEGF antibodies.
Lien S; Lowman HB
Handb Exp Pharmacol; 2008; (181):131-50. PubMed ID: 18071944
[TBL] [Abstract][Full Text] [Related]
6. The clinical implications of angiogenesis in the treatment of cancer.
Aoun E; Taher A
J Med Liban; 2002; 50(1-2):32-8. PubMed ID: 12841311
[TBL] [Abstract][Full Text] [Related]
7. VEGF receptor signaling in tumor angiogenesis.
McMahon G
Oncologist; 2000; 5 Suppl 1():3-10. PubMed ID: 10804084
[TBL] [Abstract][Full Text] [Related]
8. Role of vascular endothelial growth factor in the regulation of angiogenesis.
Ferrara N
Kidney Int; 1999 Sep; 56(3):794-814. PubMed ID: 10469350
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and its receptors in multiple myeloma.
Ria R; Roccaro AM; Merchionne F; Vacca A; Dammacco F; Ribatti D
Leukemia; 2003 Oct; 17(10):1961-6. PubMed ID: 14513045
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers.
Rosen LS
Cancer Control; 2002; 9(2 Suppl):36-44. PubMed ID: 11965229
[TBL] [Abstract][Full Text] [Related]
11. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
McCrudden KW; Hopkins B; Frischer J; Novikov A; Huang J; Kadenhe A; New T; Yokoi A; Yamashiro DJ; Kandel JJ; Middlesworth W
J Pediatr Surg; 2003 Mar; 38(3):308-14; discussion 308-14. PubMed ID: 12632340
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
Wood JM
Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
[TBL] [Abstract][Full Text] [Related]
13. Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability.
Spyridopoulos I; Luedemann C; Chen D; Kearney M; Chen D; Murohara T; Principe N; Isner JM; Losordo DW
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):901-6. PubMed ID: 12067896
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factors and angiogenesis in eye disease.
Witmer AN; Vrensen GF; Van Noorden CJ; Schlingemann RO
Prog Retin Eye Res; 2003 Jan; 22(1):1-29. PubMed ID: 12597922
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
Zachary I
IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of the vascular endothelial growth factor receptor.
Rosen LS
Hematol Oncol Clin North Am; 2002 Oct; 16(5):1173-87. PubMed ID: 12512388
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and the regulation of angiogenesis.
Ferrara N
Recent Prog Horm Res; 2000; 55():15-35; discussion 35-6. PubMed ID: 11036931
[TBL] [Abstract][Full Text] [Related]
18. VEGF: an update on biological and therapeutic aspects.
Ferrara N
Curr Opin Biotechnol; 2000 Dec; 11(6):617-24. PubMed ID: 11102799
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy.
Ferrara N; Hillan KJ; Novotny W
Biochem Biophys Res Commun; 2005 Jul; 333(2):328-35. PubMed ID: 15961063
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.
Ranieri G; Patruno R; Ruggieri E; Montemurro S; Valerio P; Ribatti D
Curr Med Chem; 2006; 13(16):1845-57. PubMed ID: 16842197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
